A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Appointments and advancements for Feb. 19, 2026
Appointments and advancements for Feb. 19, 2026
Financings for Feb. 19, 2026
Financings for Feb. 19, 2026
In the clinic for Feb. 19, 2026
In the clinic for Feb. 19, 2026
Other news to note for Feb. 19, 2026
Other news to note for Feb. 19, 2026
Regulatory actions for Feb. 19, 2026
Regulatory actions for Feb. 19, 2026
Investors unfazed by uncertainties around tariffs in med tech
Investors unfazed by uncertainties around tariffs in med tech
Opvee proxy? FDA path math adds up for Elysium’s overdose bid
Opvee proxy? FDA path math adds up for Elysium’s overdose bid
US GAO: March-ins not much of a solution for Rx prices
US GAO: March-ins not much of a solution for Rx prices
East China Normal University synthesizes adenosine receptor antagonists
East China Normal University synthesizes adenosine receptor antagonists
CLK and/or DYRK inhibitors disclosed in Tarapeutics Science patent
CLK and/or DYRK inhibitors disclosed in Tarapeutics Science patent
Onco3r Therapeutics discovers FGFR3 inhibitors
Onco3r Therapeutics discovers FGFR3 inhibitors
Shanghai SIMR Biotech patents GABA-A α5 receptor inverse agonists
Shanghai SIMR Biotech patents GABA-A α5 receptor inverse agonists
Appointments and advancements for Feb. 18, 2026
Appointments and advancements for Feb. 18, 2026
Financings for Feb. 18, 2026
Financings for Feb. 18, 2026
In the clinic for Feb. 18, 2026
In the clinic for Feb. 18, 2026
Other news to note for Feb. 18, 2026
Other news to note for Feb. 18, 2026
Regulatory actions for Feb. 18, 2026
Regulatory actions for Feb. 18, 2026
T cells store lipids and die in rheumatoid arthritis joints
T cells store lipids and die in rheumatoid arthritis joints
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page